Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 4c

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.19), $0.04 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results